Toxicity due to steroid treatment in ITP remains a concern.

Corticosteroids are the preferred first‐line treatment in ITP in guidelines. The analyses by Wang et al. shows that hospital‐registered steroid‐related toxicity occurs frequently and emphasizes that exposure should be for a limited duration of time. Commentary on: Wang et al. Longitudinal evaluation of adverse events due to steroid use in primary immune thrombocytopenia: a population‐based study. Br J Haematol 2024;204:1986‐1993. [ABSTRACT FROM AUTHOR]